The global market for genome editing should grow from $1.4 billion in 2018 to $4.4 billion by 2023, with a compound annual growth rate (CAGR) of 25.7% for the period of 2018-2023.
Report Scope:
This study is focused on the market side of genome editing and provides a comprehensive review of genome editing technologies, along with updates on the latest related progress in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and the Rest of World.
Specifically centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as each of its segments. It details recent technical breakthroughs as well as major technical issues to overcome before genome editing is applied to clinical applications. The growth driving factors and the factors that may limit the market’s growth are identified. The ethical issues, regulatory issues and intellectual property rights issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.
Report Includes:
- 44 tables
- A comprehensive overview of the global markets and technologies for genome editing within the industry
- Analyses of global market trends, with data from 2017, 2018, and projections compound annual growth rates (CAGRs) through 2023
- Segmentation of the global market by geographical regions, product types, technology types and end-user application areas
- Emphasis on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products
- Current status on the intellectual property right of the CRISPR-Cas9 genome editing technology
- Discussion of the ethical and regulatory issues, as well as patent analysis, publication analysis and research funding in this area
- Profiles of key players in the industry, including Horizon Discovery, Thermo Fisher Scientific, CRISPR Therapeutics, Caribou Biosciences Inc., Editas Medicine and Vertex
Summary
Genome editing is a revolutionary technology in the biotechnology and medical fields. It is changing many related areas that form the genome editing market. The global market for genome editing was estimated at $REDACTED billion in 2017 and is expected to rapidly increase over REDACTED% to reach $REDACTED billion in2018. In the next five years, the global market is forecasted to keep a fast pace, with a compound annual growth rate (CAGR) of REDACTED%, and reach over $REDACTED billion by 2023.While all regional markets will experience fast growth at slightly different rates, the U.S. market, whichaccounted for about REDACTED% of the global genome editing market in 2017, will keep leading theindustry with growth forecasted to reach over $REDACTED billion in 2023 at an estimated CAGR of REDACTED% from 2018 through 2023.
Key Drivers of Market Growth
This report has identified several key drivers for the growth and changes in the genome editing market -
- Development of next-generation genome editing systems with improved characteristics toward therapeutic uses, including the development of the mutants or similarities of Cas9 nuclease with improved specificity and reduced off-target effect.
- Emerging applications of genome editing such as CRISPR-Cas-based in vitro diagnosis of infectious diseases.
- Need of precision medicine.
- Need of improving drug discovery process.
- Increasing demand for synthetic genes in synthetic biology.
- Investments from both public and private sectors.
- Increased R&D expenditures in related industrial sectors.
- High prevalence of genetic birth disorders.
- Concerns about genetically modified crops.
This report identifies key revenue segments for the genome editing market from various aspects. Application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and others; product type-based market segments include editing tools, cell lines, animal models, plant breeding and therapies; editing technology-based market segments include CRISPR-Cas, TALEN, ZFN, and others such as meganucleases; and regional-based market segments include the U.S., Europe, Asia-Pacific and the Rest of World.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Key Drivers of Market Growth
Chapter 3 Current Genome Editing Technologies
Overview
History of Genome Editing
Comparison of Genome Editing
Discovery of CRISPR-Cas9
Components of CRISPR-Cas Systems
SgRNA
Cas9 Nucleases
How CRISPR-Cas Works
Advantage of the CRISPR-Cas9 System
Popularity of CRISPR Genome Editing
Major Technological Issues
Efficiency
Specificity/Off-Target Effect
Delivery Systems
Immunogenicity Risk for Clinical Applications
A New Genome Editing System: CRISPR-Cpf1
Studies on Treating Diseases Using Genome Editing
Impact of Genome Editing
Future of CRISPR
Chapter 4 Applications of Genome Editing
Introduction
Academic Research
Drug Discovery and Development
Clinical Therapy
Non-transgenic Breeding
Diagnostics
Other Applications
Chapter 5 Market Segmentation and Forecast
Market Overview
Major Players
Market Segments by Region
Market Segments by Application
Market Segments by Technology
Market Segments by Product Type
Chapter 6 Contract Services Market Analysis
Market Overview
Major Players
Market Share and Projection
Comparison with Products Segment
Chapter 7 Research Market Analysis
Market Overview
Market Share and Projections
Patent Analysis
Publication Analysis
Research Funding Analysis
Chapter 8 Drug Development Market Analysis
Market Overview
Market Share and Forecast
Chapter 9 Agricultural Biotechnology Market Analysis
Market Overview
Market Share and Forecast
Chapter 10 Clinical Market Analysis
Market Overview
Market Share and Forecast
Comparison with Non-clinical Market
Chapter 11 Competition Landscape and Opportunities
Overview
Growth Strategies
Licensing and Agreements
Collaborations with Big Biopharmaceutical Companies
In-house R&D Program
Startup
Strategic Alliance and Joint Venture
Focus on Specific Application Areas
Venture Capital Funding
Opportunities
Chapter 12 Factors Influencing the Genome Editing Market
Introduction
Driving Forces
New Genome Editing Technologies and Related Advancements
New Applications of Genome Editing
Need for Precision Medicine
Need for Improving Drug Discovery Process
Increasing Demand for Synthetic Genes in Synthetic Biology
Investments from Both Public and Private Sectors
Increased R&D Expenditures in Related Industrial Sectors
High Prevalence of Genetic Birth Disorders
Concerns on Genetically Modified Crops
Factors Limiting the Market’s Growth
Stringent Regulatory Frameworks and Time-Consuming Approval Processes
Research Funding
Patent Disputes
Governmental Policies and Regulations
Regulatory Uncertainty on Genome Edited Crops
Ethical Issues
Chapter 13 Company Profiles
ADDGENE
AGILENT TECHNOLOGIES INC.
ALDEVRON
ALLELE BIOTECHNOLOGY
AMERICAN TYPE CULTURE COLLECTION (ATCC)
APPLIED STEMCELL INC.
ARBOR BIOTECHNOLOGIE INC.
ASTRAZENECA
ATUM (DNA2.0)
AUSTRALIAN BIORESOURCES LTD.
AXOL BIOSCIENCE LTD.
BEAM THERAPEUTICS
BIOCYTOGEN
BIO-RAD LABORATORIES INC.
BIOTOOLS CO. LTD.
BLUEBIRD BIO
B-MOGEN BIOTECHNOLOGIES INC.
CALYXT INC.
CANOPY BIOSCIENCES
CARIBOU BIOSCIENCES INC.
CASZYME
CELLECTA INC.
CELLECTICS S.A.
CIBUS
CRISPR THERAPEUTICS
DESKTOP GENETICS
EDITAS MEDICINE
GENECOPOEIA
GENEWIZ
GENSCRIPT
HORIZON DISCOVERY
INNOVATIVE GENOMICS INITIATIVE
INTELLIA THERAPEUTICS INC.
INTEGRATED DNA TECHNOLOGIES
IXCELLS BIOTECHNOLOGIES
JUNO THERAPEUTICS
LONZA
MAMMOTH BIOSCIENCES
MERCK KGAA (SIGMA-ALDRICH)
NEW ENGLAND BIOLABS
ORIGENE TECHNOLOGIES
PRECISION BIOSCIENCES INC.
RECOMBINETICS
REGENERON PHARMACEUTALS INC.
SANGAMO BIOSCIENCES
SOLENTIM INC.
SYNTHEGO
SYSTEM BIOSCIENCES
TAKARA BIO USA INC. (CLONTECH)
THERMO FISHER SCIENTIFIC
TOOLGEN INC.
TRANS GENIC INC.
TRANSOMIC TECHNOLOGIES INC.
TRANSPOSAGEN BIOPHARMACEUTICALS INC.
VERTEX PHARMACEUTICALS INC.
Trends Market Research © Copyright 2020. All Rights Reserved.